Holen Sie sich die Stockscreener-App
200.37
0.15%
-0.31
Handel nachbörslich:
200.50
0.13
+0.06%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$200.68
Offen:
$200
24-Stunden-Volumen:
1.68M
Relative Volume:
0.87
Marktkapitalisierung:
$46.93B
Einnahmen:
$250.74B
Nettoeinkommen (Verlust:
$1.55B
KGV:
30.64
EPS:
6.5398
Netto-Cashflow:
$4.39B
1W Leistung:
+0.00%
1M Leistung:
+0.26%
6M Leistung:
-5.99%
1J Leistung:
+31.18%
1-Tages-Spanne:
$199.25
$201.44
1-Wochen-Bereich:
$197.88
$202.77
52-Wochen-Spanne:
$137.75
$233.60
Cardinal Health Inc Stock (CAH) Company Profile
Firmenname
Cardinal Health Inc
Sektor
Branche
Telefon
(614) 757-3033
Adresse
7000 CARDINAL PLACE, DUBLIN, OH
Compare CAH vs MCK, COR, HSIC, AHG
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CAH
Cardinal Health Inc
|
200.37 | 47.00B | 250.74B | 1.55B | 4.39B | 6.5398 |
MCK
Mckesson Corp
|
754.40 | 92.09B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
270.78 | 53.49B | 328.68B | 2.55B | 1.56B | 13.03 |
HSIC
Henry Schein Inc
|
73.90 | 8.45B | 13.18B | 419.00M | 521.00M | 3.2704 |
AHG
Akso Health Group Adr
|
1.60 | 1.31B | 14.85M | -136.07M | 7.25M | -0.4726 |
Cardinal Health Inc Stock (CAH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-06-03 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-02-05 | Hochstufung | Jefferies | Hold → Buy |
| 2025-01-08 | Hochstufung | TD Cowen | Hold → Buy |
| 2025-01-07 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-01-06 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-12-13 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-12-04 | Fortgesetzt | Mizuho | Outperform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-02-09 | Hochstufung | Argus | Hold → Buy |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-12-14 | Eingeleitet | Wells Fargo | Underweight |
| 2023-07-10 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-03-31 | Eingeleitet | Citigroup | Neutral |
| 2023-02-03 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2022-11-04 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-05-26 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-05-18 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2022-04-12 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-08-06 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-08-05 | Herabstufung | BofA Securities | Buy → Underperform |
| 2021-05-10 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2021-01-08 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-11-02 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-09-25 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-07-20 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-05-15 | Hochstufung | UBS | Neutral → Buy |
| 2020-04-23 | Fortgesetzt | Credit Suisse | Neutral |
| 2020-03-20 | Hochstufung | BofA/Merrill | Underperform → Buy |
| 2020-02-12 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2020-02-07 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-12-16 | Herabstufung | Guggenheim | Buy → Neutral |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-08-27 | Herabstufung | Argus | Buy → Hold |
| 2019-08-20 | Hochstufung | Guggenheim | Neutral → Buy |
| 2019-04-18 | Eingeleitet | Guggenheim | Neutral |
| 2019-01-17 | Eingeleitet | UBS | Neutral |
| 2018-11-16 | Herabstufung | Leerink Partners | Outperform → Mkt Perform |
| 2018-04-24 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-04-02 | Hochstufung | Argus | Hold → Buy |
| 2018-03-08 | Eingeleitet | Barclays | Equal Weight |
| 2018-02-27 | Fortgesetzt | BofA/Merrill | Underperform |
| 2018-01-05 | Eingeleitet | Evercore ISI | In-line |
Alle ansehen
Cardinal Health Inc Aktie (CAH) Neueste Nachrichten
Cardinal Health (CAH) Valuation Check After Recent Sideways Share Performance - Yahoo Finance
Cardinal Health Inc. stock (US14149Y1082): Analyst target cut meets steady dividend story - AD HOC NEWS
Cardinal Health, Inc. (CAH) Stock Analysis: Unveiling a 22% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews
Top Cardinal Health (CAH) Competitors 2026 - MarketBeat
Cardinal Health Inc. stock (US14149Y1082): Dividend move and healthcare distribution in focus - AD HOC NEWS
Spotting Winners: Cardinal Health (NYSE:CAH) And Healthcare Providers & Services Stocks In Q1 - Yahoo Finance
Precision Trading with Cardinal Health Inc. (CAH) Risk Zones - Stock Traders Daily
Cardinal Health stock (US14149Y1082): focus on cost cuts and pharma growth after latest quarterly re - AD HOC NEWS
Here's Why You Should Add Cardinal Health Stock to Your Portfolio Now - Yahoo Finance
Possible Bearish Signals With Cardinal Health Insiders Disposing Stock - Yahoo Finance
Cardinal Health (CAH) Stock Price, News & Analysis $CAH - MarketBeat
Cardinal Health Inc. stock (US14149Y1082): shares react to Q3 2026 earnings beat - AD HOC NEWS
Cardinal Health Inc. stock (US14149Y1082): steady gains and healthcare exposure for US investors - AD HOC NEWS
Is CAH Becoming the Backbone of US Healthcare Infrastructure? - TradingView
Cardinal Health (CAH) is a Top-Ranked Value Stock: Should You Buy? - Eastern Progress
Which Is a Better Investment, BrightSpring Health Services, Inc. or Cardinal Health, Inc. Stock? - AAII
Daily Brief Health Care: Dermavon Holdings, Alebund Pharmaceuticals Jiangsu, Alnylam Pharmaceuticals, Artrya , Bavarian Nordic A/S, Cardinal Health, Dexcom Inc, American Shared Hospital Servi, Eli Lilly & Co, Abeona Therapeutics and more - Smartkarma
Cardinal Health stock (US14149Y1082): dividend hike and higher FY2026 outlook - AD HOC NEWS
Cardinal Health Inc. stock outperforms competitors on strong trading day - MarketWatch
Top Companies Driving Innovation In Specimen Bag Zip Closure Solutions - SNS Insider
CAH Technical Analysis | Trend, Signals & Chart Patterns | CARDINAL HEALTH INC (NYSE:CAH) - ChartMill
Cardinal Health Inc. stock (US14149Y1082): dividend hike and higher FY2026 guidance in focus - AD HOC NEWS
Cardinal Health dividend preview: strong Q3 earnings point to May payout boost - MSN
Why is Cardinal Health stock sinking Thursday? - MSN
Cardinal Health (CAH) Is Up 6.3% After Raising 2026 EPS Outlook and Trimming Tax Guidance - Sahm
Cardinal Health Is One of the S&P 500’s Biggest Decliners Today. A Guidance Hike Didn’t Matter. - Barron's
Does Cardinal Health's (CAH) Higher Dividend and Guidance Hint at a New Capital Allocation Play? - Yahoo Finance
Cardinal Health Inc. stock (US14149Y1082): EPS beat contrasts with recent share-price weakness - AD HOC NEWS
Do options traders know something about Cardinal Health stock we don't? - MSN
Cardinal Health Inc. stock (US14149Y1082): earnings beat meets fresh momentum signal - AD HOC NEWS
CAH Stock Price, Quote & Chart | CARDINAL HEALTH INC (NYSE:CAH) - ChartMill
Cardinal Health Inc (CAH) Stock Up 4.3% but GF Value Says Overva - GuruFocus
CAH Stock Down Nearly 9.4% YTD: Should You Buy, Hold or Sell? - TradingView
Cardinal Health stock (US14149Y1082): Beats Q3 Earnings, Analysts Trim Price Targets - AD HOC NEWS
Cardinal Health Was Supposed to Beat UnitedHealth. Did It? Will It? - Yahoo Finance
BofA Securities Maintains Cardinal Health(CAH.US) With Buy Rating, Maintains Target Price $240 - Moomoo
Baird Keeps Outperform on Cardinal Health (CAH) Following Earnings Update - Insider Monkey
Cardinal Health Inc stock (US14149Y1082): Recent earnings beat highlights strong performance - AD HOC NEWS
Transcript : Cardinal Health, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-13-2026 08 - marketscreener.com
Can CAH Sustain Growth on Booming Pharmaceutical & Specialty Segment? - TradingView
Analysts Offer Insights on Healthcare Companies: Cardinal Health (CAH) and Dexcom (DXCM) - The Globe and Mail
Should Value Investors Buy Cardinal Health (CAH) Stock? - Yahoo Finance
Cardinal Health Extends Beyond Distribution With Surgical Case Cart Automation - Yahoo Finance
Cardinal Health's (NYSE:CAH) Earnings Offer More Than Meets The Eye - Moomoo
We Think Cardinal Health's (NYSE:CAH) Solid Earnings Are Understated - Yahoo Finance
Cardinal Health stock (US14149Y1082): Q4 revenue beats estimates by 1.2% - AD HOC NEWS
Cardinal Health, Inc. (CAH) Stock Analysis: Strong Buy Ratings and 33.55% Potential Upside Propel Investor Interest - DirectorsTalk Interviews
Is It Time To Reassess Cardinal Health (CAH) After Its Multi Year Share Price Surge - Sahm
Liberty One Defensive Dividend Growth ETF 's Cardinal Health Inc(CAH) Holding History - GuruFocus
Here's why you should add Cardinal Health stock to your portfolio now - MSN
Here's Why Cardinal Health (CAH) is a Strong Value Stock - Yahoo Finance
Finanzdaten der Cardinal Health Inc-Aktie (CAH)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.50%
4.58%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):